{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T02:00:55Z","timestamp":1788919255636,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2002,3,1]],"date-time":"2002-03-01T00:00:00Z","timestamp":1014940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2002,3,1]],"date-time":"2002-03-01T00:00:00Z","timestamp":1014940800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2002,3]]},"DOI":"10.1023\/a:1015761618314","type":"journal-article","created":{"date-parts":[[2002,12,29]],"date-time":"2002-12-29T00:56:06Z","timestamp":1041123366000},"page":"161-165","source":"Crossref","is-referenced-by-count":36,"title":["Acute Delirium Induced by Metoprolol"],"prefix":"10.1007","volume":"16","author":[{"given":"Alexander A.","family":"Fisher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Jeffery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"5087881_CR1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/ajh\/4.2.151","volume":"4","author":"G Olsson","year":"1991","unstructured":"Olsson G, Tuomilehto J, Berglund G, et al. Primary prevention of sudden cardiovascular death in hypertensive patients. Mortality results from the MAPHY Study. Am J Hypertens 1991;4:151\u2013158.","journal-title":"Am J Hypertens"},{"key":"5087881_CR2","first-page":"125","volume":"95","author":"MJ. Kendall","year":"2000","unstructured":"Kendall MJ. Clinical trial data on the cardioprotective effects of beta-blockade. Basic Res Cardiol 2000;95:125\u2013130.","journal-title":"Basic Res Cardiol"},{"key":"5087881_CR3","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/0002-8703(80)90112-X","volume":"100","author":"JM. Cruickshank","year":"1980","unstructured":"Cruickshank JM. The clinical importance of cardioselectivity and lipophilicity in beta blockers. Am Heart J 1980;100:160\u2013178.","journal-title":"Am Heart J"},{"key":"5087881_CR4","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/0002-8703(88)90105-6","volume":"116","author":"FM Gengo","year":"1988","unstructured":"Gengo FM, Gabos C. Central nervous system considerations in the use of beta-blockers, angiotensin-converting enzyme inhibitors, and thiazide diuretics in managing essential hypertension. Am Heart J1988;116:305\u2013310.","journal-title":"Am Heart J"},{"key":"5087881_CR5","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1001\/archinte.1989.00390030020005","volume":"149","author":"JE Dimsdale","year":"1989","unstructured":"Dimsdale JE, Newton RP, Joist T. Neuropsychological side effects of beta-blockers. Arch Intern Med 1989;149:514\u2013525.","journal-title":"Arch Intern Med"},{"key":"5087881_CR6","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0163-7258(90)90092-G","volume":"46","author":"J McAinsh","year":"1990","unstructured":"McAinsh J, Cruickshank JM. Beta-blockers and central nervous system side effects. Pharmacol Ther 1990;46:163\u2013197.","journal-title":"Pharmacol Ther"},{"key":"5087881_CR7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1055\/s-2007-979572","volume":"29","author":"CH Gleiter","year":"1996","unstructured":"Gleiter CH, Deckert J. Adverse CNS-effects of betaadrenoceptor blockers. Pharmacopsychiatry 1996;29:201\u2013211.","journal-title":"Pharmacopsychiatry"},{"key":"5087881_CR8","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/med.2610010405","volume":"1","author":"L Patel","year":"1981","unstructured":"Patel L, Turner P. Central actions of beta-adrenoceptor blocking drugs in man. Med Res Rev 1981;1:387\u2013410.","journal-title":"Med Res Rev"},{"key":"5087881_CR9","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/BF00543714","volume":"28","author":"A. Westerlund","year":"1985","unstructured":"Westerlund A. Central nervous system side-effects with hydrophilic and lipophilic beta-blockers.EurJ Clin Pharmacol 1985;28:73\u201376.","journal-title":"EurJ Clin Pharmacol"},{"key":"5087881_CR10","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF00543713","volume":"28","author":"JR Cove-Smith","year":"1985","unstructured":"Cove-Smith JR, Kirk CA. CNS-related side-effects with metoprolol and atenolol. Eur J Clin Pharmacol 1985;28:69\u201372.","journal-title":"Eur J Clin Pharmacol"},{"key":"5087881_CR11","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1161\/01.CIR.75.1.204","volume":"75","author":"JB Kostis","year":"1987","unstructured":"Kostis JB, Rosen RC. Central nervous system effects of beta-adrenergic-blocking drugs: The role of ancillary properties. Circulation1987;75:204\u2013212.","journal-title":"Circulation"},{"key":"5087881_CR12","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/j.1875-9114.1987.tb04029.x","volume":"7","author":"DE. Drayer","year":"1987","unstructured":"Drayer DE.Lipophilicity, hydrophilicity, and the central nervous system side effects of beta blockers. Pharmacotherapy 1987;7:87\u201391.","journal-title":"Pharmacotherapy"},{"key":"5087881_CR13","first-page":"1142, 1144","volume":"44","author":"S. Ahmad","year":"1991","unstructured":"Ahmad S. Metoprolol-induced delirium perpetuated by propafenone. Am Fam Physician 1991;44:1142, 1144.","journal-title":"Am Fam Physician"},{"key":"5087881_CR14","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1056\/NEJM198210283071829","volume":"307","author":"WB White","year":"1982","unstructured":"White WB, Riotte K. Propranolol and white rabbits.NEngl J Med 1982;307:558\u2013559.","journal-title":"NEngl J Med"},{"key":"5087881_CR15","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"CA Naranjo","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239\u2013245.","journal-title":"Clin Pharmacol Ther"},{"key":"5087881_CR16","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1001\/jama.1967.03130090066023","volume":"201","author":"DL Parker","year":"1967","unstructured":"Parker DL, Hodge JR. Delirium in a coronary care unit. JAMA1967;201:702\u2013703.","journal-title":"JAMA"},{"key":"5087881_CR17","doi-asserted-by":"crossref","first-page":"938","DOI":"10.7326\/0003-4819-90-6-938","volume":"90","author":"ES Gershon","year":"1979","unstructured":"Gershon ES, Goldstein RE, Moss AJ, van Kammen DP. Psychosis with ordinary doses of propranolol. Ann Intern Med 1979;90:938\u2013939.","journal-title":"Ann Intern Med"},{"key":"5087881_CR18","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/0002-8703(73)90139-7","volume":"86","author":"DJ Greenblatt","year":"1973","unstructured":"Greenblatt DJ, Koch-Weser J. Adverse reactions to propranolol in hospitalized medical patients: A report from the Boston Collaborative Drug Surveillance Program. Am Heart J 1973;86:478\u2013484.","journal-title":"Am Heart J"},{"key":"5087881_CR19","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/archinte.1987.00370010043011","volume":"147","author":"FM Gengo","year":"1987","unstructured":"Gengo FM, Huntoon L, McHugh WB. Lipid-soluble and water-soluble beta-blockers. Comparison of the central nervous system depressant effect. Arch Intern Med 1987;147:39\u201343.","journal-title":"Arch Intern Med"},{"key":"5087881_CR20","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/jnnp.48.2.101","volume":"48","author":"FM Gengo","year":"1985","unstructured":"Gengo FM, Ermer JC, Carey C, Kalonaros GC, McHugh WB. The relationship between serum concentrations and central nervous system actions of metoprolol. J Neurol Neurosurg Psychiatry 1985;48:101\u2013106.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"5087881_CR21","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2165\/00003088-199834050-00003","volume":"34","author":"DG Le Couteur","year":"1998","unstructured":"Le Couteur DG, McLean AJ. The aging liver. Drug clearance and an oxygen diffusion barrier hypothesis. Clin Pharmacokinet 1998;34:359\u2013373.","journal-title":"Clin Pharmacokinet"},{"key":"5087881_CR22","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1053\/jhep.2001.22754","volume":"33","author":"DG Le Couteur","year":"2001","unstructured":"Le Couteur DG, Cogger VC, Markus AM, et al. Pseudocapillarization and associated energy limitation in the aged rat liver. Hepatology 2001;33:537\u2013543.","journal-title":"Hepatology"},{"key":"5087881_CR23","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/S0016-5085(96)70073-2","volume":"111","author":"PL Hickey","year":"1996","unstructured":"Hickey PL, McLean AJ, Angus PW, Choo EF, Morgan DJ. Increased sensitivity of propranolol clearance to reduced oxygen delivery in the isolated perfused cirrhotic rat liver. Gastroenterology1996;111:1039\u20131048.","journal-title":"Gastroenterology"},{"key":"5087881_CR24","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1001\/archinte.1988.00380040017002","volume":"148","author":"ED. Frohlich","year":"1988","unstructured":"Frohlich ED. Beta-blockers and mental performance. Arch Intern Med 1988;148:777\u2013778.","journal-title":"Arch Intern Med"},{"key":"5087881_CR25","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/0002-9149(66)90071-3","volume":"18","author":"SA. Stephen","year":"1966","unstructured":"Stephen SA. Unwanted effects of propranolol.AmJ Cardiol 1966;18:463\u2013472.","journal-title":"AmJ Cardiol"},{"key":"5087881_CR26","first-page":"119","volume":"54","author":"J Conway","year":"1978","unstructured":"Conway J, Greenwood DT, Middlemiss DN. Central nervous actions of beta-adrenoreceptor antagonists. Clin Sci Mol Med 1978;54:119\u2013124.","journal-title":"Clin Sci Mol Med"},{"key":"5087881_CR27","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1136\/bmj.1.6121.1182","volume":"1","author":"R. Fleminger","year":"1978","unstructured":"Fleminger R. Visual hallucinations and illusions with propranolol. Br Med J1978;1:1182.","journal-title":"Br Med J"},{"key":"5087881_CR28","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1176\/ajp.139.4.540-c","volume":"139","author":"PD Fleming","year":"1982","unstructured":"Fleming PD, Drachman DA. Propranolol, hallucinations, and sleep disturbance. Am J Psychiatry 1982;139:540\u2013541.","journal-title":"Am J Psychiatry"},{"key":"5087881_CR29","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/00004714-198708000-00012","volume":"7","author":"JH Shore","year":"1987","unstructured":"Shore JH, Fraunfelder FT, Meyer SM. Psychiatric side effects from topical ocular timolol, a beta-adrenergic blocker. J Clin Psychopharmacol1987;7:264\u2013267.","journal-title":"J Clin Psychopharmacol"},{"key":"5087881_CR30","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1001\/jama.1996.03530350034031","volume":"275","author":"SK Inouye","year":"1996","unstructured":"Inouye SK, Charpentier PA. Precipitating factors for delirium in hospitalized elderly persons. Predictive model and interrelationship with baseline vulnerability. JAMA 1996;275:852\u2013857.","journal-title":"JAMA"},{"issue":"Suppl2","key":"5087881_CR31","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/oxfordjournals.ageing.a008086","volume":"28","author":"ST. O'Keeffee","year":"1999","unstructured":"O'Keeffee ST. Delirium in the elderly. Age Ageing 1999;28(Suppl 2):5\u20138.","journal-title":"Age Ageing"},{"key":"5087881_CR32","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2165\/00002018-199921020-00004","volume":"21","author":"SL Gray","year":"1999","unstructured":"Gray SL, Lai KV, Larson EB. Drug-induced cognition disorders in the elderly: Incidence, prevention and management. Drug Saf1999;21:101\u2013122.","journal-title":"Drug Saf"},{"key":"5087881_CR33","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/jama.1990.03440080075027","volume":"263","author":"J Francis","year":"1990","unstructured":"Francis J, Martin D, Kapoor WN. A prospective study of delirium in hospitalized elderly. JAMA 1990;263:1097\u20131101.","journal-title":"JAMA"},{"key":"5087881_CR34","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2165\/00002512-199915010-00002","volume":"15","author":"AR Moore","year":"1999","unstructured":"Moore AR, O'Keeffe ST. Drug-induced cognitive impairment in the elderly. Drugs Aging 1999;15:15\u201328.","journal-title":"Drugs Aging"},{"key":"5087881_CR35","first-page":"132","volume":"5","author":"PT. Trzepacz","year":"2000","unstructured":"Trzepacz PT. Is there a final common neural pathway in delirium? Focus on acetylcholine and dopamine. Semin Clin Neuropsychiatry 2000;5:132\u2013148.","journal-title":"Semin Clin Neuropsychiatry"},{"key":"5087881_CR36","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF00543705","volume":"28","author":"JM Cruickshank","year":"1985","unstructured":"Cruickshank JM, Neil-Dwyer G. Beta-blocker brain concentrations in man. Eur J Clin Pharmacol 1985;28:21\u201323.","journal-title":"Eur J Clin Pharmacol"},{"key":"5087881_CR37","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1111\/j.1365-2125.1987.tb03215.x","volume":"24","author":"PM McCaffrey","year":"1987","unstructured":"McCaffrey PM,Riddell JG, Shanks RG.Anassessment of the partial agonist activity of Ro 31-1118, flusoxolol and pindolol in man. Br J Clin Pharmacol 1987;24:571\u2013580.","journal-title":"Br J Clin Pharmacol"},{"key":"5087881_CR38","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1365-2125.1983.tb01480.x","volume":"15","author":"P. Turner","year":"1983","unstructured":"Turner P. Beta-adrenoceptor blockers reduce blood pressure in normal subjects. Br J Clin Pharmacol 1983;15:128.","journal-title":"Br J Clin Pharmacol"},{"key":"5087881_CR39","first-page":"155","volume":"221","author":"K Brismar","year":"1987","unstructured":"Brismar K, Mogensen L, Wetterberg L. Depressed melatonin secretion in patients with nightmares due to betaadrenoceptor blocking drugs. ActaMedScand 1987;221:155\u2013158.","journal-title":"ActaMedScand"},{"key":"5087881_CR40","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.0954-6820.1988.tb17690.x","volume":"223","author":"K Brismar","year":"1988","unstructured":"Brismar K, Hylander B, Eliasson K, Rossner S,Wetterberg L. Melatonin secretion related to side-effects of betablockers from the central nervous system. Acta Med Scand 1988;223:525\u2013530.","journal-title":"Acta Med Scand"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1015761618314.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1015761618314\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1015761618314.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T19:10:24Z","timestamp":1751051424000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1015761618314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,3]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2002,3]]}},"alternative-id":["5087881"],"URL":"https:\/\/doi.org\/10.1023\/a:1015761618314","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,3]]}}}